Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | JNJ | LLY |
|---|---|---|
| Price | $271.25 | $1,187.15 |
| Change today | ▲ 0.77% | ▲ 3.14% |
| Market cap | $653.67B | $1.12T |
| Return, 3 months | +13.1% | +6.4% |
| Return, year to date | +33.2% | +11.0% |
| Return, 1 year | +57.0% | +61.0% |
| P/E (TTM) | 31.5 | 39.9 |
| P/B | 7.7 | 33.0 |
| P/E percentile vs own 5y | 88th | 5th |
| Dividend yield | 1.93% | 0.54% |
| Revenue growth (YoY, latest qtr) | +6.6% | +47.7% |
| Net profit growth (YoY) | -0.1% | +25.3% |
| Gross margin | 67.9% | 83.4% |
| Operating margin | 26.8% | 49.7% |
| Net margin | 21.5% | 33.5% |
| Return on equity | 25.7% | 102.4% |
| Analyst target vs. price | +5.7% | +15.6% |
| Analyst buy share | 78% | 86% |
| RSI (14) | 57 | 51 |
| 30-day volatility | 19.0% | 26.1% |
| Max drawdown, 1 year | -11.0% | -23.2% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.